Challenges to clinical trials
Clinical trial recruitment poses significant challenges to drug development
Enrollment duration as key barrier for AD trials
AD trials take longer time than trials of other disease areas
Average trial durations in years
Using ki:e SB-C for pre-screening will significantly lower the enrollment duration.
Speed up enrollment process
Pre-screening using ki:e SB-C biomarker
Validity of the ki:e SB-C biomarker
Under the hood of pre-screening — psychometric properties of ki:e SB-C
correlation with the MMSE
Strong correlation of the ki:e SB-C biomarker with MMSE total score.
discriminating between stages
Significant group differences between Dementia, MCI and HC.
ki:e SB-C performance in a retrospective example study
Real world numbers of the ki:e SB-C in pre-screening including early AD
Use case of ki:e as pre-screening tool in the screening roadmap
Integration into existing remote CRO screening funnel
Get in touch
& work with us
We’re looking forward to working with you!